2008 annual financial data
Sarepta Therapeutics 2008 Operating cash flow margin
Direct answer
Operating cash flow margin was -58.05%.
Operating income was -27,457,567 USD and net income was -23,952,625 USD.
Operating cash flow was -12,339,313 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 21,258,155 USD
- Operating income
- -27,457,567 USD
- Net income
- -23,952,625 USD
- Operating cash flow
- -12,339,313 USD